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PharmacovigilanceAbstract Adverse reactions are the recognized hazards of drug therapy and they can occur with
any class of drugs and many studies revealed that the incidence is more in case of antibiotics.
The main aim of this study was to detect and analyze Adverse Drug Reactions of antibiotics in
inpatients of a tertiary care hospital. A prospective spontaneous reporting study by active and pas-
sive methods was carried out for a period of six months. A total of 49 ADRs were reported during
the study period with male predominance (53.06%) and geriatric age group. More number of ADRs
was from General Medicine and Pediatric departments in which the most affected organ systems
were the GIT (38.77%) and the skin (30.61%). The antibiotic classes mostly accounted were ceph-
alosporins (34.69%) followed by ﬂuoroquinolones and others in which type A reactions were more
compared to type B and 59.18% of them were predictable. The severity assessment revealed that
most of them were moderate (63.26%) followed by mild and severe reactions. Of the reported reac-
tions, 55.10% were deﬁnitely preventable and causality assessment was done which showed that
71.42% of the reactions were probable, possible (18.36%), deﬁnite (10.20%) and no reactions were
unlikely. The study concluded that Adverse Drug Reactions to antibiotics are common and some of
them resulted in increased healthcare cost due to the need of some interventions and increased
length of hospital stay. The health system should promote the spontaneous reporting of Adverse
Drug Reactions to antibiotics, proper documentation and periodic reporting to regional pharmaco-
vigilance centers to ensure drug safety.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Drugs are the most common medical interventions, primarily
used to relieve sufferings. But it has been recognized long
ago that drug themselves can prove fatal; as the saying rightly
goes ‘‘Drugs are Double Edged Weapons’’. Adverse reaction
monitoring and reporting are very important in identifying
304 M. Shamna et al.the adverse reaction trends in local population (Phatak and
Nagari, 2003).
In its simple deﬁnition an ADR is any undesirable effect of
a drug beyond its anticipated therapeutics occurring during
clinical use. The WHO deﬁnes an ADR as ‘‘any response to
a drug which is noxious and unintended, and which occurs
at doses normally used in man for prophylaxis, diagnosis or
therapy of disease, or for the modiﬁcation of physiologic func-
tion.’’ Thus this deﬁnition excludes overdose (either accidental
or intentional), drug abuse, and treatment failure and drug
administration errors (Ramesh et al., 2003).
Drug toxicity is a major limitation in providing health care
to patients at a global level. It affects patient’s recovery as well
as the economy of health care. With the increase in production
of various pharmaceutical products, newer drugs are being
introduced every year. Hence, the need for an active surveil-
lance system to remove the harmful drugs that have entered
the market was well realized by the WHO. This has been the
basis for starting the international drug monitoring program
by the WHO (Surendiran et al., 2010).
Adverse reactions are recognized hazards of drug therapy.
Adverse Drug Reactions (ADRS) are important causes of mor-
tality and morbidity in both hospitalized and ambulatory pa-
tients. In many countries ADRs rank among the top 10
leading causes of mortality. So there is a need to study ADRs
seriously to create awareness about ADRs among patients to
motivate health care professionals in the hospital to report ADRs
to minimize the risk. Early detection, evaluation and monitoring
of ADR are essential to reduce harm to patients and thus im-
prove public health (Pirmohamed and Brecken, 1998).
The safety of drug prescribing has become a highly visible
topic in medicine, due in part to research suggesting that there
are important ADRs caused by commonly used medications.
Patients constitute a vulnerable group with regard to rational
drug prescribing since many new drugs are released into the
market without the beneﬁt of even limited experience. This
deﬁciency causes a practitioner to often prescribe drugs in an
‘off label’ manner, thereby increasing the risk of drug toxicity.
As more drugs are marketed and as more individuals take mul-
tiple drugs, the occurrence of Adverse Drug Reaction will
probably continue to increase. Therefore, better approaches
must be devised for reporting and assessment and management
of individuals who present with drug induced diseases
(Mohammed Misbah et al., 2010).
ADRs have a considerable negative impact on both health
and healthcare costs. ADR monitoring and reporting activity
is in its infancy in India. India is a developing country with
a large drug consuming population. It is the fourth largest pro-
ducer of pharmaceuticals in the world with more than 6000 li-
censed drug manufacturers and over 60,000 branded
formulations. Thus it is essential that the drug treatment
should be safe, efﬁcacious and cost effective. It is also emerging
as a clinical trial hub exposing larger population to newer drug
treatments. It is the need of the hour to identify Adverse Drug
Reactions as early as possible and to prevent them if possible,
to ensure the well-being of the patient at a reasonable cost. The
Ministry of Health and Family Welfare had initiated the Na-
tional Pharmacovigilance Program (NPP) on 1st January
2005 which was further revived in July 2010. This program is
overseen by the Central Drugs Standard Control Organization
(CDSCO), New Delhi (Vikas et al., 2004; Amrita and Singh,
2011).Adverse reaction can occur with any class of drugs. Accord-
ing to a study conducted by Novotny et al., the most trouble-
some classes of drugs contributing to Adverse Drug Reactions
were antibiotics followed antitumor agents, they are responsi-
ble for the recorded adverse effects in approximately 16% and
15% of cases, respectively (Novotny and Novotny, 1999).
Antibiotics belong to different classes such as penicillins,
cephalosporins, sulfonamides, and aminoglycosides, and they
vary in respect of their mechanism of actions and adverse ef-
fects. Antibiotics are used commonly in routine practice for
treatment and prophylaxis of various disease conditions (Tri-
pathi, 2007).
Over half of all hospitalized patients are treated with anti-
microbial agents and their use account for 20–50% of drug
expenditures in hospitals. More than 70% of ICU patients re-
ceive antibiotics for therapy or prophylaxis, with much of this
use being empiric and over half of the recipients receiving mul-
tiple agents. The total costs associated with antibiotics are not
only related to antibiotic use itself, but also to co-medication
and adverse drug events. In Darchy’s report, antibiotics ac-
counted for 11% of iatrogenic disease. Classen states that,
although adverse events seem to occur in a small proportion
of antibiotic courses, the frequency of antibiotic use makes
them account for 23% of all adverse events recorded (Stavreva
et al., 2008; Granowitz and Brown, 2008).
The main aim of this study was to detect and analyze Ad-
verse Drug Reactions (ADR) to antimicrobial drugs in hospi-
talized patients of a tertiary care hospital.
2. Methodology
A prospective spontaneous reporting study involving, active
methods (pharmacist actively looking for suspected ADRs)
and passive methods (stimulating prescribers to report suspected
ADRs) was carried out in all departments of a tertiary care
referral hospital, Kerala for a period of one year. Patients of
all age groups who developed Adverse Drug Reactions of anti-
biotics were included for the study. The data for the study were
taken from case sheets, investigation reports of patients who had
experienced an ADR, personal interviews with reporting per-
sons or clinicians, personal interviews with patient or patient’s
attendant, past history of medication use, which were generally
obtained from, prescriptions from the past, reports of Medical
and surgical interventions, referral letters, etc.
The causality assessment of the reported ADRs was carried
out using the ‘‘Naranjo causality assessment scale’’. In the
Naranjo Algorithm, the drug reaction can be classiﬁed as def-
inite, probable, or possible. The modiﬁed Schumock and
Thornton scale classiﬁes ADRs as deﬁnitely preventable, prob-
ably preventable and not preventable based on a set of ques-
tions for each level. The modiﬁed Hartwig and Siegel scale
classiﬁes severity of ADR as mild, moderate or severe with var-
ious levels according to factors like requirements for change in
treatment, duration of hospital stay, and the disability pro-
duced by the Adverse Drug Reaction.
3. Results
During the study period, a total of 49 antibiotic Adverse Drug
Reactions were reported among 15,037 patients admitted for
antibiotic use. The incidence rate of antibiotic Adverse Drug
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Figure 1 Division of ADRs based on gender of the patient.
20.40%
34.69%
44.89% Children 
Adult
Geriatrics
Figure 2 Division of ADRs based on the age group of patients.
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male patients 26 (53.06%) predominated over females 23
(46.93%) in ADR occurrence. It is depicted in Fig. 1. Fig. 2
showed that maximum number of ADRs were reported
from the general medicine 12(24.48%), followed by Pediatrics
9(18.36%), Dermatology 7(14.28%), Pulmonology 6(12.24%),
Cardiology 5(10.20%), Nephrology 4(8.16%), orthope-
dics:orthopedics 3(6.12%), Gastroenterology 2(4.08%) and
Neurology 1(0.20%). Fig. 3 shows the age wise distribution
of the total population and revealed that the geriatric patients
were more accounted 22(44.89%), followed by adults
17(34.69%), and children 10(20.40%). Results revealed that
the GIT 19(38.77%) was the most affected organ system by
Adverse Drug Reactions due to antibiotics followed by the
skin 15(30.61%), others 5(10.20%), CVS 4(8.16%), hematol-
ogy 3(6.12%), CNS 2(4.08%) and endocrine system
1(2.04%). The antibiotic classes affected with ADRs are
shown in Fig. 4 which revealed that cephalosporins were the
most accounted antibiotic class 17 (34.69%) followed by
ﬂuoroquinolones 15(30.61%), penicillins 7(14.28%), others
3(6.12%), polyene 2(4.08%), aminoglycosides 2(4.08%), mac-
rolides 1(2.04%), oxazolidinone 1(2.04%), azoles 1(2.04%). Of
the reported ADRs, Type A 38(77.55%) was the most com-
mon compared to Type B 11(22.44%) reactions according to
the ADR classiﬁcation by Rawlin and Thomson (Fig. 5). In
28(57.14%) cases the suspected drug was withdrawn while10.20%
14.28%
4.08%
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Figure 3 Number of ADRs receivno change was made with the suspected drug in 17(20.83%)
and the dose was altered in 15(23.61%) cases. From this study,
it was found out that there was a recovery from ADRs in total
of 44 patients (89.79%) although 0% had fatal ADRs. Out of
this, 5(10.20%) cases were found to be unknown. Speciﬁc
treatment was given in 16(32.65%) while 33(67.34%) cases re-
quired symptomatic treatment and there were no cases that re-
quired no treatment. Predictability analysis showed that
29(59.18%) of them were predictable while 20(40.81%) of
them were not predictable Fig. 6. Of the reported ADRs mod-
erate reactions accounted for 31(63.26%) followed by mild
reactions 14(28.57%). Only 4(8.16%) of the reactions were se-
vere (Fig. 7). Preventability of reported ADRs was assessed
using the modiﬁed Shumock and Thornton method. Using this
scale, results revealed that 27(55.10%) of the ADRs were def-
initely preventable, while 19(38.77%) were probably prevent-
able and 3(6.12%) were not preventable (Fig. 8). Fig. 9
shows the causality assessment of reported ADRs as per the
Naranjo scale and revealed that 71.42% were probable,
9(18.36%) were possible, 5(10.20%) were deﬁnite and 0% were
unlikely.
4. Discussion
Antibiotics are used for treatment and prophylaxis of various
infectious conditions and are considered as safer drugs when
used rationally. But, like all other drugs, they also show some
Adverse Drug Reactions in various patient conditions. This
study tried to ﬁnd out the pattern of Adverse Drug Reactions
of antibiotic drug class in the post marketing surveillance stud-
ies to ﬁnd out the effects in a large and diverse population. In
the studies carried out in Nigerian children by Priyadharsini
et al. antibiotics were the most accounted drug class in ADR
occurrence and they were the second most accounted in an-
other study conducted by Hussain et al. (Oshikoya et al.,
2007; Priyadharsini et al., 2011; Mohammed Misbah et al.,
2010).
The incidence rate of antibiotic adverse reactions in this
study was found to be comparatively low when compared to
other studies. This lower incidence rate was due to the effective
intervention of clinical pharmacist in our hospital such as
implementation of drop boxes in all nursing stations, deliver-
ing periodic ADR awareness classes, active involvement of
clinical pharmacy and Pharm. D students in clinical activities
and coordination of quality control unit in the hospital.8.16%
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Figure 4 Therapeutic classes of antibiotics implicated to cause ADRs.
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Figure 8 Preventability of reported ADRs (using the modiﬁed
Shumock and Thornton method).
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Drug Reactions may be due to majority of the admitted pa-
tients were male with more antibiotic use during the study per-
iod. Analysis of the age wise distribution showed the
predominance of geriatric patients followed by adults and this
result implied that the geriatric patients were more prone to
antibiotic Adverse Drug Reactions due to age related pharma-0.00%
20.00%
40.00%
60.00%
80.00%
28.57%
63.26%
Severity
Figure 7 Level of severity of reported ADRs (Ucokinetic and pharmacodynamic changes and the presence of
co-morbid illnesses and multiple drugs along with infectious
diseases. The study conducted by Jimmy Jose et al. and Suthar
and Desai also showed the male predominance but the age
group most accounted were adults in both the studies whereas
two other studies by Starveva et al. and Hussain et al. showed
adult age group and female predominance (Jose, 2008; J.V
et al., 2011; Stavreva et al., 2008; Mohammed Misbah et al.,
2010).
More number of antibiotic Adverse Drug Reactions were
detected in General Medicine and Pediatrics departments
and may be due to an increased use of antibiotics in these
departments for treatment and prophylaxis of various diseases.
Even though the pediatric department accounted next to the
general medicine department, the ADR occurrence was least
accounted in the pediatric age group due to the less number
of admitted pediatric patients when compared to the adult
and geriatrics which were distributed in different departments.
The documented antibiotic Adverse Drug Reactions are
mainly affecting the GIT and skin and this study also pointed
out the same. The study of Benjamin Horen et al. and Annie
also found the predominance of the gastrointestinal system fol-8.16%
Mild
Moderate
Severe
sing the modiﬁed Hartwig and Siegel scale).
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Figure 9 Causality assessment of ADRs (using the Naranjo scale).
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Jonville-Bera, 2002). Four other studies showed the predomi-
nance of cutaneous manifestations (Mohammed Misbah
et al., 2010; Oshikoya et al., 2007; Jose, 2008).
The cephalosporins and ﬂuoroquinolones were the most
used antibiotic class in the inpatient settings, so that the re-
ported ADRs were also more in these drug classes. A study
conducted by Stavreva et al. also revealed the predominance
of cephalosporins whereas ﬂuoroquinolones were most ac-
counted in a study conducted by Hussain et al. while vancomy-
cin and penicillins were most frequent in the study of
Priyadharsini et al. (Stavreva et al., 2008; Mohammed Misbah
et al., 2010; Priyadharsini et al., 2011).
Analysis of the type of reported ADRs according to Rawlin
and Thompson revealed Type A predominance. This result is
in line with the study conducted by Oshikoya et al. and Starv-
eva et al. but in another study by Suthar and Desai, all the re-
ported reactions were Type B reactions (Oshikoya et al., 2007;
Stavreva et al., 2008; Jose, 2008). Type A reactions are dose re-
lated and thus were preventable from their known pharmacol-
ogy and therefore all of them were potentially avoidable. Eva
states that Type B reactions comprise approximately 10–15%
of all ADRs and include hypersensitivity drug reactions
(Gomes and Demoly, 2005). Even though, most of them were
moderate reactions, they resulted in an increased health care
cost due to an increased length of stay and need of some med-
ical interventions as a result of incidence of Adverse Drug
Reactions.
The analysis of the fate of the suspected drugs showed that
the drug was withdrawn in many of the cases and the dose al-
tered in some while no change was made with the suspected
drug in others because of considering the risk beneﬁt ratio in
speciﬁc patients and in some cases, the use of antibiotic was
according to the culture and sensitivity reports. Drug rechal-
lenge was not done in any of the cases. Some of the Healthcare
providers were not much aware of the importance of reporting
and follow up of those reactions and they were not willing to
change the drug or alter the dose. Vast majority of the patients
were recovered from the ADR because none of the reported
reactions was fatal. Jimmy Jose et al. also found that moderate
and mild reactions were more but some severe reactions also
reported while majority of the suspected drugs was withdrawn
and 70% of the patients recovered (Jose, 2008). All the cases
needed treatment for recovery from the reactions in which
many of them were treated symptomatically and speciﬁc treat-
ment was provided to others because 8% of the reactions were
severe and others were moderate and mild according to theHartwig scale. The study carried out by Stavreva et al. and Pri-
yadharsini et al. also showed that the severity was moderate
for the reported Adverse Drug Reactions while severe reac-
tions were more followed by moderate in a study by Oshikoya
et al. (Stavreva et al., 2008; Priyadharsini et al., 2011; Osh-
ikoya et al., 2007).
Predictability of the reactions was based on the incidence of
the reactions and literature reports and found that majority of
them were predictable. Preventability analysis revealed that
majority of the reactions was deﬁnitely preventable followed
by probably preventable with only less number of them were
not preventable. This is in line with the study of Oshikoya
et al. and Jimmy Jose et al. (Oshikoya et al., 2007; Priyadhar-
sini et al., 2011). According to a study conducted by Bates,
antibiotics were responsible for 9% of preventable ADRs
and 30% of non-preventable ADRs (Bates et al., 1995). The
prevalence of deﬁnitely preventable reactions revealed that
the failure of rational antibiotic use in the hospital. The causal-
ity assessment of ADRs had been done using the Naranjo scale
in which no reactions were found to be unlikely and majority
were probable with a less number of possible and deﬁnite reac-
tions. These data correlate with the study of Starveva et al. Pri-
yadharsini et al. and Jimmy Jose et al. and opposite to the
study by Oshikoya et al. because they reported more number
of deﬁnite reactions (Stavreva et al., 2008; Oshikoya et al.,
2007; Priyadharsini et al., 2011; Jose, 2008).5. Conclusion
The study concluded that the spontaneous reporting of Ad-
verse Drug Reactions of antibiotics is fairly good in our hospi-
tal setting. The effort of this study revealed the occurrence of
comparatively less number of antibiotic adverse reactions
and their impact on patients of a developing country like In-
dia. The results provided an insight to the healthcare providers
on the importance of monitoring and reporting of Adverse
Drug Reactions.
Adverse Drug Reactions are one of the drug related prob-
lems in the hospital setting and is a challenge for ensuring drug
safety. Antibiotics comprise the major volume of the drug fam-
ily and inpatient prescriptions and thus are the most irratio-
nally prescribed drug class. So implementation of antibiotic
guidelines for the hospital scenario and strict adherence should
be ensured to promote the rational use. The development and
use of clinical decision support systems can promote rational
antibiotic use. The health system should promote the sponta-
308 M. Shamna et al.neous reporting of Adverse Drug Reactions to antibiotics and
other drugs, proper documentation and periodic reporting to
regional pharmacovigilance centers to ensure drug safety.
The active involvement of a well trained clinical pharmacist
for detecting the Adverse Drug Reactions and delivering the
awareness classes for the healthcare professionals regarding
the need of reporting the incident could improve the scenario
in under-reported hospitals.
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